The University of Queensland Nov 8 2024 Recruitment is underway for a clinical trial testing a vaccine candidate produced with The University of Queensland's molecular clamp technology against life-threatening respiratory viruses. Vicebio, the vaccine company licensed to develop the UQ technology, has developed a new candidate vaccine to fight respiratory syncytial virus (RSV) and human metapneumovirus (hMPV). Both viruses cause respiratory tract diseases which may be severe, especially in